Correlation Between Apexigen and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apexigen and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apexigen and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apexigen and ZyVersa Therapeutics, you can compare the effects of market volatilities on Apexigen and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apexigen with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apexigen and ZyVersa Therapeutics.
Diversification Opportunities for Apexigen and ZyVersa Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Apexigen and ZyVersa is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apexigen and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Apexigen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apexigen are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Apexigen i.e., Apexigen and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Apexigen and ZyVersa Therapeutics
If you would invest (100.00) in Apexigen on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Apexigen or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Apexigen vs. ZyVersa Therapeutics
Performance |
Timeline |
Apexigen |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
ZyVersa Therapeutics |
Apexigen and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apexigen and ZyVersa Therapeutics
The main advantage of trading using opposite Apexigen and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apexigen position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.Apexigen vs. Leap Therapeutics | Apexigen vs. Zura Bio Limited | Apexigen vs. X4 Pharmaceuticals | Apexigen vs. Phio Pharmaceuticals Corp |
ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |